GRM3 and central nervous system cancer: Even though metabotropic glutamate receptors 3 and 5 (mGluR3 and mGluR5) are expressed in glioma cells (Condorelli et al., 1997; Stepulak et al., 2009), their roles in cell mobility have not been elucidated.